ATE466086T1 - Expec-spezifische proteine, entsprechende gene und ihre verwendungen - Google Patents

Expec-spezifische proteine, entsprechende gene und ihre verwendungen

Info

Publication number
ATE466086T1
ATE466086T1 AT03724923T AT03724923T ATE466086T1 AT E466086 T1 ATE466086 T1 AT E466086T1 AT 03724923 T AT03724923 T AT 03724923T AT 03724923 T AT03724923 T AT 03724923T AT E466086 T1 ATE466086 T1 AT E466086T1
Authority
AT
Austria
Prior art keywords
polypeptides
expec
specific proteins
corresponding genes
conserved
Prior art date
Application number
AT03724923T
Other languages
English (en)
Inventor
Sonia Escaich
Original Assignee
Mutabilis S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mutabilis S A filed Critical Mutabilis S A
Application granted granted Critical
Publication of ATE466086T1 publication Critical patent/ATE466086T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03724923T 2002-03-06 2003-03-06 Expec-spezifische proteine, entsprechende gene und ihre verwendungen ATE466086T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02290556A EP1342784A1 (de) 2002-03-06 2002-03-06 ExPEC-spezifische Proteine, entsprechende Gene und ihre Verwendungen
PCT/EP2003/002925 WO2003074553A2 (en) 2002-03-06 2003-03-06 Expec-specific proteins, genes encoding them and uses thereof

Publications (1)

Publication Number Publication Date
ATE466086T1 true ATE466086T1 (de) 2010-05-15

Family

ID=27741246

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03724923T ATE466086T1 (de) 2002-03-06 2003-03-06 Expec-spezifische proteine, entsprechende gene und ihre verwendungen

Country Status (8)

Country Link
US (2) US20060188514A1 (de)
EP (3) EP1342784A1 (de)
JP (2) JP2006502696A (de)
AT (1) ATE466086T1 (de)
AU (2) AU2003227537A1 (de)
CA (1) CA2478277A1 (de)
DE (1) DE60332324D1 (de)
WO (1) WO2003074553A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030148324A1 (en) * 2001-02-02 2003-08-07 Edouard Bingen Polynucleotides which are of nature B2/D+ A- and which are isolated from E. coli, and biological uses of these polynucleotides and of their polypeptides
EP1570856A3 (de) * 2004-02-26 2005-10-12 Institut National De La Sante Et De La Recherche Medicale (Inserm) Eine Impfstoffzusammensetzung, die ein Immunoadjuvants-Verbindung bestehend aus einem RHO GTPase-Aktivator.
EP1580195A1 (de) * 2004-03-26 2005-09-28 Mutabilis SA Zusammensetzungen von Polypeptiden spezifisch für pathogene ExPEC E. coli, sowie deren Anwendung als Vakzine und in der Immuntherapie
NZ599345A (en) * 2005-02-18 2013-07-26 Novartis Vaccines & Diagnostic Immunogens from uropathogenic Escherichia Coli
AU2006214064B2 (en) 2005-02-18 2012-04-26 J. Craig Venter Institute, Inc. Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli
WO2008020330A2 (en) * 2006-08-16 2008-02-21 Novartis Ag Immunogens from uropathogenic escherichia coli
ITMI20090946A1 (it) 2009-05-28 2010-11-29 Novartis Ag Espressione di proteine ricombinanti
PL2464658T3 (pl) 2009-07-16 2015-03-31 Novartis Ag Immunogeny z Escherichia coli o zniesionej toksyczności
US11905286B2 (en) 2018-08-09 2024-02-20 Antabio Sas Diazabicyclooctanones as inhibitors of serine beta-lactamases
EP3833665B1 (de) 2018-08-09 2023-07-19 Antabio SAS Diazabicyclooctanones als inhibitoren von serin-beta-lactamasen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
ES2076895B1 (es) * 1994-02-04 1996-08-16 Ind Farma Especial Fimbrias-adhesinas de tipo 1 y p aisladas de nuevas cepas de e. coli, procedimiento para su obtencion y aplicaciones.
AU5431196A (en) * 1995-03-24 1996-10-16 Ophidian Pharmaceuticals Treatment for verotoxin-producing escherichia coli
US6365723B1 (en) * 1998-12-04 2002-04-02 Wisconsin Alumni Research Foundation Sequences of E. coli O157
US20030148324A1 (en) * 2001-02-02 2003-08-07 Edouard Bingen Polynucleotides which are of nature B2/D+ A- and which are isolated from E. coli, and biological uses of these polynucleotides and of their polypeptides
EP1328641A2 (de) * 2000-03-10 2003-07-23 Institut National De La Sante Et De La Recherche Medicale (Inserm) Polynukleotidem aus b2/d+ a- e. coli und deren verwndungen

Also Published As

Publication number Publication date
AU2010201045A1 (en) 2010-04-08
JP2006502696A (ja) 2006-01-26
EP2253707A3 (de) 2011-03-02
WO2003074553A3 (en) 2004-03-25
EP1481062B1 (de) 2010-04-28
EP2253707A2 (de) 2010-11-24
WO2003074553A2 (en) 2003-09-12
EP1342784A1 (de) 2003-09-10
CA2478277A1 (en) 2003-09-12
JP2010189411A (ja) 2010-09-02
AU2003227537A1 (en) 2003-09-16
DE60332324D1 (de) 2010-06-10
EP1481062A2 (de) 2004-12-01
HK1073478A1 (en) 2005-10-07
US20060188514A1 (en) 2006-08-24
AU2003227537A2 (en) 2003-09-16
US20100260789A1 (en) 2010-10-14

Similar Documents

Publication Publication Date Title
DE60217320D1 (de) Gonokokkenproteine und nukleinsäuren
ATE388230T1 (de) Neisseria meningitidis antigene und zusammenstellungen
DK1185691T3 (da) Genomiske neisseriasekvenser og fremgangmåder til anvendelse deraf
NO20034244L (no) Mikrobielt fôr for akvakultur og landbruk
DK1741784T3 (da) 85kDa-antigen fra neisseria
ATA1302001A (de) Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen
DE122010000010I1 (de) Antikörper gegen tnf, zusammensetzungen, verfahren und verwendungen
ATE466086T1 (de) Expec-spezifische proteine, entsprechende gene und ihre verwendungen
EP1451578A4 (de) Angiopoetinähnliches protein 3 angptl3 enthaltende zusammensetzung und verfahren zu dessen verwendung
ATE557041T1 (de) Peptid-vakzinen gegen streptokokken der gruppe a
WO2002097048A3 (en) ANTI-p40 IMMUNOGLOBULIN DERIVED PROTEINS, COMPOSITIONS, METHODS AND USES
CY1107950T1 (el) Νεϊσσεριακες συνθεσεις εμβολιου και μεθοδοι
DE60323994D1 (de) Verfahren zur herstellung von 2-chlor-1,1,1,2,3,3,3-heptafluorpropan, hexafluorpropen und 1,1,1,2,3,3,3-heptafluorpropan
WO2002029018A3 (en) Divinyl ether synthase gene and protein, and uses thereof
ATE551069T1 (de) Mucin-fusionspolypeptid-vakzine, zusammensetzungen und ihre verwendung
ATE382056T1 (de) Virulenz gene, proteine, und ihre verwendung
WO2000012535A3 (en) Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof
ATE513033T1 (de) Expression von proteinen in aus nabelschnurblut gewonnenen endothelzellen
DE60125507D1 (de) Nukleinsäuren und Proteine des mph3 Gens aus Mycoplasma hypopneumoniae und deren Verwendung
ATE335766T1 (de) Antikörper gegen caspase-8, ihre herstellung und verwendung
WO2001092524A3 (en) Myosin-like gene expressed in human heart and muscle
WO2003000717A3 (de) Identifizierung von ses-3 (spr-5) aus c. elegans sowie dessen verwendungen
WO2003000889A3 (de) Identifizierung von ses-1 aus c. elegans sowie dessen verwendung
GB0409559D0 (en) Polypeptide
ATE354639T1 (de) Virulenz gene, proteine, und ihre verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties